Pediatric cancers have unique genetic vulnerabilities

Most cancer drugs that target specific genetic mutations are designed for adult cancers rather than those in children, partly because pediatric cancers have fewer mutations. To look for more ways to target childhood cancers, researchers at the Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute and Boston Children's Hospital decided to look for genetic dependencies in various pediatric cancers.

Read more: https://medicalxpress.com/news/2021-03-pediatric-cancers-unique-genetic-vulnerabilities.html